- Abstract
- Keywords
- Introduction
- Chemistry of BD
- Antineoplastic effects of BD in human malignancies
- Anti-metastatic effects of BD
- Potential anti-inflammatory effects of BD
- Pharmacokinetics, toxicity and metabolism
- Clinical application of BD
- Conclusion and future directions
- Abbreviations
- Declarations
- References
-
Citing Article List
The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Therapeutic targets for metabolic dysfunction-associated steatotic liver disease and their roles in hepatocellular carcinoma”.No. Publication Date Citing Article 1 2025 Jai Kumar, Misha Hasan, Sana Mohsin, Mojtaba Hussain Alzaher, Tripti Nagar, Adeena Jamil, Ali Ahmed, Vamsi Krishna Lavu, Sarwan Kumar. Assessing the efficacy of farnesoid X receptor agonists in the management of metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis, Clinics and Research in Hepatology and Gastroenterology. 2025; 49: 102530102530. https://doi.org/10.1016/j.clinre.2025.102530 2 2025 Shu-ting Xu, Ting-ting Li, Guang-yi Liao, Wenmin Li, Wanli Huang, Lihaopeng Cao, Shan-shan Chen, Xiao Yang, Yu-qing Zhou, Rong Yu, Chuanquan Lin. 2025; https://doi.org/10.2139/ssrn.5234360 -
